Peter de Gooyer

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Peter de Gooyer

Sep 25, 2024, 14:47 | Blog

Kai-Keen Shiu: NICHE2, NICHE3 and IMHOTEP summarised by Smitha Krishnamurthi

Kai-Keen Shiu shared a post on X by Smitha Krishnamurthi adding: "NICHE2, NICHE3 and IMHOTEP…

Sep 20, 2024, 13:05 | Insight

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer

Top Biomedical Science shared a post on X about a recent paper by Peter de…

Jun 28, 2024, 13:48 | Societies

Peter de Gooyer awarded as the best poster presenter in rectal cancer at ESMOGI24

Chiara Cremolini, Associate Professor in Medical Oncology at the University of Pisa, shared a post…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023